About 8% of these cases were measured as severe COVID-19. Of 1,007,269 encounters, 918 were identified as positive for COVID-19. The third category was measured by abnormal chest x-ray. In the second category, symptoms included: any of low white blood cell count, low lymphocyte count, and raised C-reactive protein concentration. In the first category, symptoms included: fever greater than 37.5 degrees Celsius, apnea, cough, tachypnea, respiratory distress or recession, supplemental oxygen requirement, and vomiting or diarrhea. Severeness was classified as any case that contained symptoms from 2 of 3 categories. Outcomes measured included incidence of COVID-19 infection, incidence of severe illness, geographic distribution of infection, and treatment received.

Neonates aged under 28 days diagnosed with COVID-19 between March 1, 2020, and February 28, 2021, were included in the study. To study the outcomes of neonatal COVID-19, investigators conducted a cross-sectional study across the United States on the incidence, geographic distribution, severity, features of presentation, and clinical outcomes.ĭata was gathered from the Cerner Real-World Database, which contains data from over 120 United States health systems. However, newer variants have become highly transmissible, causing cases to rise in neonates.

In instances of neonatal COVID-19, symptoms are often mild, with a good overall prognosis. This has been attributed to inherent protective factors present in young children. COVID-19 can cause severe infection in neonates in rare instances, according to a recent study.Ībout 3% of COVID-19 cases in the United States have been in pediatric patients aged 0 to 4 years, making rates significantly lower in this population.

Icd 10 code for sepsis